Bone marrow trephine biopsy

被引:127
作者
Bain, BJ [1 ]
机构
[1] Univ London Imperial Coll Sci Technol & Med, Sch Med, Dept Haematol, London W2 1NY, England
关键词
trephine biopsy; bone marrow; haematological diagnosis;
D O I
10.1136/jcp.54.10.737
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Trephine biopsies of the bone marrow should be carried out, when clinically indicated, by trained individuals following a standard operating procedure. A bone marrow aspiration should be performed as part of the same procedure. For patient safety and convenience, biopsies are usually performed on the posterior iliac crest. The biopsy specimen should measure at least 1.6 cm and, if it does not, consideration should be given to repeating the procedure, possibly on the contralateral iliac crest. If bone marrow aspiration is found to be impossible, imprints from the biopsy specimen should be obtained. Otherwise, the specimen is placed immediately into fixative and after fixation is embedded in a resin or, more usually, decalcified and embedded in paraffin wax. Thin sections are cut and are stained, as a minimum, with haematoxylin and eosin and with a reticulin stain. A Giemsa stain is also desirable. A Perls' stain does not often give useful information and is not essential in every patient. The need for other histochemical or immunohistochemical stains is determined by the clinical circumstances and the preliminary findings. Trephine biopsy sections should be examined and reported in a systematic manner, assessment being made of the bones, the vessels and stroma, and the haemopoietic and any lymphoid or other tissue. Assessment should begin with a very low power objective, the entire section being examined. Further examination is then done with an intermediate and high power objective. Ideally, reporting of trephine biopsy sections should be done by an individual who is competent in both histopathology and haematology, and who is able to make an appropriate assessment of both the bone marrow aspirate and the trephine biopsy sections. When this is not possible, there should be close consultation between a haematologist and a histopathologist. The report should both describe the histological findings and give an interpretation of their importance. A signed or computer authorised report should be issued in a timely manner. If the report is a preliminary, this must be clearly stated.
引用
收藏
页码:737 / 742
页数:6
相关论文
共 34 条
[21]  
IHDE DC, 1979, BLOOD, V53, P677
[22]  
INGLE JN, 1978, CANCER, V41, P670, DOI 10.1002/1097-0142(197802)41:2<670::AID-CNCR2820410235>3.0.CO
[23]  
2-V
[24]  
ISLAM A, 1997, MANUAL BONE MARROW E
[25]   VALUE OF BILATERAL BONE-MARROW BIOPSY SPECIMENS IN NON-HODGKINS-LYMPHOMA [J].
JUNEJA, SK ;
WOLF, MM ;
COOPER, IA .
JOURNAL OF CLINICAL PATHOLOGY, 1990, 43 (08) :630-632
[26]   HISTOPLASMOSIS IN PATIENTS WITH ACQUIRED-IMMUNODEFICIENCY-SYNDROME - HEMATOLOGIC AND BONE-MARROW MANIFESTATIONS [J].
KURTIN, PJ ;
MCKINSEY, DS ;
GUPTA, MR ;
DRIKS, M .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1990, 93 (03) :367-372
[27]  
MACINTYRE EA, 1987, EUR J HAEMATOL, V39, P66
[28]  
PEDERSEN LM, 1993, EUR J HAEMATOL, V51, P52
[29]   Deterioration in performance in obtaining bone marrow trephine biopsy cores from children [J].
Reid, MM ;
Roald, B .
JOURNAL OF CLINICAL PATHOLOGY, 1999, 52 (11) :851-852
[30]   Adequacy of bone marrow trephine biopsy specimens in children [J].
Reid, MM ;
Roald, B .
JOURNAL OF CLINICAL PATHOLOGY, 1996, 49 (03) :226-229